Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Therapeutic prostate-specific antigen (PSA) –targeted poxviral vaccines for prostate cancer have been well tolerated. PROSTVAC-VF treatment was evaluated for safety and for prolongation of progression-free survival (PFS) and overall survival (OS) in a randomized, controlled, and blinded pha...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kantoff, Philip W., Schuetz, Thomas J., Blumenstein, Brent A., Glode, L. Michael, Bilhartz, David L., Wyand, Michael, Manson, Kelledy, Panicali, Dennis L., Laus, Reiner, Schlom, Jeffrey, Dahut, William L., Arlen, Philip M., Gulley, James L., Godfrey, Wayne R.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2010
Θέματα:
Original Reports
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834462/
https://ncbi.nlm.nih.gov/pubmed/20100959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.0597
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια